← All stocks

Janux Therapeutics, Inc.

JANX Net selling
CIK 0001817713 #2496 in the set updated 19 Sep 2026
Bought (120 mo)
$207.28M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$365.17M
$6.73M on a plan · $19.32M straight out of an exercise
Sold at will
$339.13M
60 of 103 sales
Net
−$157.90M
−$131.85M against sales at will

By person

24 insiders · 125 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Avalon Ventures XI, L.P. entity
10% owner
$15.69M (2)
$205.38M (47)
−$189.69M
8,666,664
14.18%
$121.58M
+102.9%
RA CAPITAL MANAGEMENT, L.P. entity
Director
$135.21M (8)
+$135.21M
1,060,156
1.73%
$14.87M
Lichter Jay
10% owner
$15.69M (2)
$82.30M (4)
−$66.61M
7,826,510
12.80%
$109.80M
Reardon Tighe
Acting Chief Financial Officer
$15.69M (2)
$45.04M (2)
−$29.36M
7,992,445
13.07%
$112.13M
+129.3%
Campbell David Alan
President and CEO
$6.61M (11) scheduled
−$6.61M
264,742
0.4330%
$3.71M
−20.3%
Meyer Andrew Hollman
Chief Business Officer
$4.22M (19) scheduled
−$4.22M
83,095
0.1359%
$1.17M
+18.0%
ORBIMED ADVISORS LLC entity
Director
$12.00M (2)
$10.59M (6)
+$1.41M
513,496
0.8399%
$7.20M
Thompson Peter A.
Director
$12.00M (2)
$10.59M (6)
+$1.41M
513,496
0.8399%
$7.20M
Bregua Corp entity
10% owner
$999.99K (1)
+$999.99K
3,749,250
6.13%
$52.60M
DiRaimondo Thomas
Chief Scientific Officer
$266.11K (3) scheduled
−$266.11K
155,825
0.2549%
$2.19M
+44.4%
Doyle Janeen Noel
Chief Corp. & Bus. Dev. Ofcr
$56.94K (1)
−$56.94K
75,941
0.1242%
$1.07M
Dobek Maria
Vice President, Accounting
$48.95K (2)
−$48.95K
32,270
0.0528%
$452.72K
+1,038%
McIver Zachariah
Chief Medical Officer
$37.26K (1)
−$37.26K
52,286
0.0855%
$733.52K
Winter Charles M.
Chief Technical Officer
$32.97K (1)
−$32.97K
106,321
0.1739%
$1.49M
+86.1%
Gujrathi Sheila
Director
118,889
0.1945%
$1.67M
+13.2%
CAPPS VICKIE L
Director
79,598
0.1302%
$1.12M
+24.3%
Go William
Chief Medical Officer
44,000
0.0720%
$617.28K
Robinson Byron
Chief Strategy Officer
28,000
0.0458%
$392.81K
DOBMEIER ERIC
Director
15,481
0.0253%
$217.18K
Hernday Natasha
Director
15,481
0.0253%
$217.18K
Simson Jake
Director
11,750
0.0192%
$164.84K
Kung Winston
Director
11,750
0.0192%
$164.84K
Barrett Ronald W
Director
11,750
0.0192%
$164.84K
McNulty Alana B.
Director
6,250
0.0102%
$87.68K
Insider
Date
Role
Action
Shares
Price
Amount
Meyer Andrew Hollman
1 Dec 2025
Chief Business Officer
Sold after exercise
633
$33.52
$21.22K
Meyer Andrew Hollman
1 Dec 2025
Chief Business Officer
Sold after exercise
2,700
$32.85
$88.71K
Meyer Andrew Hollman
14 Nov 2025
Chief Business Officer
Sold after exercise
3,333
$30.00
$99.99K
Meyer Andrew Hollman
28 Oct 2025
Chief Business Officer
Sold after exercise
16,665
$30.06
$500.99K
Meyer Andrew Hollman
1 May 2025
Chief Business Officer
Sold after exercise
400
$32.60
$13.04K
Meyer Andrew Hollman
1 May 2025
Chief Business Officer
Sold after exercise
2,933
$31.95
$93.70K
Meyer Andrew Hollman
21 Apr 2025
Chief Business Officer
Sold after exercise
3,334
$30.00
$100.02K
Meyer Andrew Hollman
3 Mar 2025
Chief Business Officer
Sold after exercise
901
$32.85
$29.60K
Meyer Andrew Hollman
3 Mar 2025
Chief Business Officer
Sold after exercise
2,433
$31.88
$77.58K
Meyer Andrew Hollman
3 Feb 2025
Chief Business Officer
Sold after exercise
100
$43.60
$4.36K
Meyer Andrew Hollman
3 Feb 2025
Chief Business Officer
Sold after exercise
816
$42.77
$34.90K
Meyer Andrew Hollman
3 Feb 2025
Chief Business Officer
Sold after exercise
2,418
$42.08
$101.74K
Avalon Ventures XI, L.P.
17 Oct 2024
10% owner
Sold after exercise
1,843
$50.02
$92.19K
Avalon Ventures XI, L.P.
16 Oct 2024
10% owner
Sold after exercise
10,957
$50.80
$556.62K
Avalon Ventures XI, L.P.
16 Oct 2024
10% owner
Sold after exercise indirect
30,094
$50.61
$1.52M
Avalon Ventures XI, L.P.
16 Oct 2024
10% owner
Sold after exercise indirect
5,710
$50.61
$288.98K
Avalon Ventures XI, L.P.
16 Oct 2024
10% owner
Sold after exercise
29,474
$50.61
$1.49M
Avalon Ventures XI, L.P.
16 Oct 2024
10% owner
Sold after exercise indirect
61,445
$49.69
$3.05M
Avalon Ventures XI, L.P.
16 Oct 2024
10% owner
Sold after exercise indirect
11,657
$49.69
$579.24K
Avalon Ventures XI, L.P.
16 Oct 2024
10% owner
Sold after exercise
60,179
$49.69
$2.99M
Avalon Ventures XI, L.P.
30 Sep 2024
10% owner
Sold after exercise
958
$46.24
$44.30K
Meyer Andrew Hollman
27 Sep 2024
Chief Business Officer
Sold after exercise
50,000
$45.96
$2.30M
Avalon Ventures XI, L.P.
27 Sep 2024
10% owner
Sold after exercise
1,826
$46.19
$84.34K
Avalon Ventures XI, L.P.
27 Sep 2024
10% owner
Sold after exercise indirect
1,542
$47.74
$73.62K
Avalon Ventures XI, L.P.
27 Sep 2024
10% owner
Sold after exercise indirect
293
$47.74
$13.99K
Avalon Ventures XI, L.P.
27 Sep 2024
10% owner
Sold after exercise
1,511
$47.74
$72.14K
Avalon Ventures XI, L.P.
27 Sep 2024
10% owner
Sold after exercise indirect
46,861
$46.42
$2.18M
Avalon Ventures XI, L.P.
27 Sep 2024
10% owner
Sold after exercise indirect
8,894
$46.42
$412.86K
Avalon Ventures XI, L.P.
27 Sep 2024
10% owner
Sold after exercise
45,894
$46.42
$2.13M
Lichter Jay
13 Sep 2024
10% owner
Sold after exercise
3,815
$46.68
$178.08K
Avalon Ventures XI, L.P.
9 Sep 2024
10% owner
Sold after exercise
2,182
$42.33
$92.36K

What was left out

Form 4 filings counted 136
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 22
Sales on a Rule 10b5-1 plan 12
Sales straight out of an exercise 31
Sales at will 60
Transactions with no price 0
Shares from compensation/vesting 36,004,274
Sales filed before the plan box existed 12
History held since 14 Jun 2021